MedPath

Holmium Laser Uretherotomy in Combination With Intralesional Steroids in Bulbar Uretheral Stricture

Not Applicable
Completed
Conditions
Urethral Stricture
Interventions
Procedure: Laser uretherotomy with triamcinolone
Procedure: Laser uretherotomy
Registration Number
NCT05078788
Lead Sponsor
Ain Shams University
Brief Summary

the purpose is to evaluate the outcome of visual internal uretherotomy with Holmium laser along with intralesional steroid injection.

Detailed Description

In this study, the investigator evaluates the efficacy of Holmium laser in combination with intra lesional steroid injection in the treatment of bulbar urethral strictures

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
124
Inclusion Criteria
  1. Presence of obstructive symptoms,
  2. Short segment strictures (stricture length <2 cm) as evident on radiological studies, i.e. retrograde urethrography and micturating cystourethrography.
  3. Peak flow rate on uroflowmetry less than 15 ml/s
Read More
Exclusion Criteria
  1. Complete obliteration of lumen of urethra on urethroscopy,
  2. Balanitis Xerotica Obliterans,
  3. Age less than 18 years,
  4. Multiple strictures,
  5. Active urinary tract infection,
  6. Recurrent Strictures.
  7. Prior internal uretherotomy
  8. Prior urethroplasty
  9. Pan-anterior urethral strictures
  10. Posterior stenosis
  11. Those who lost to follow up
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laser uretherotomy with intralesional steroidsLaser uretherotomy with triamcinoloneUsing holmium laser uretherotomy with injection of 80 mg of triamcinolone (diluted with normal saline to 10 ml) in the treatment of bulbar uretheral stricture
Laser uretherotomyLaser uretherotomyUsing Holmium laser uretherotomy only in the treatment of bulbar uretheral stricture
Primary Outcome Measures
NameTimeMethod
the maximum flow rate (Qmax) is >15 ml/s at 3 and 6 months after procedure3 and 6 months

The procedure will be accepted as successful when the maximum flow rate (Qmax) is \>15 ml/s.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain Shams university

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath